Literature DB >> 10201317

Adenosine-induced cardiac pause for endovascular embolization of cerebral arteriovenous malformations: technical case report.

J Pile-Spellman1, W L Young, S Joshi, H Duong, M C Vang, A Hartmann, R A Kahn, D A Rubin, C J Prestigiacomo, N D Ostapkovich.   

Abstract

OBJECTIVE: Extremely high flow through arteriovenous malformations (AVMs) may limit the safety and effectiveness of endovascular glue therapy. To achieve a more controlled deposition of glue, we used transient but profound systemic hypotension afforded by an intravenously administered bolus of adenosine to induce rapidly reversible high-degree atrioventricular block. METHODS AND CASE REPORT: A patient with a large high-flow occipital AVM fed primarily by the posterior cerebral artery underwent n-butyl cyanoacrylate glue embolization. Nitroprusside-induced systemic hypotension did not adequately reduce flow through the nidus, as determined by contrast injection in the feeding artery. In a dose-escalation fashion, boluses of adenosine were administered to optimize the dose and verify that there was no flow reversal in the AVM and no other unexpected hemodynamic abnormalities by arterial pressure measurements and transcranial Doppler monitoring of the posterior cerebral artery feeding the AVM. Thereafter, 64 mg of adenosine was rapidly injected as a bolus to provide 10 to 15 seconds of systemic hypotension (approximately 20 mm Hg). Although there were conducted beats and some residual forward flow through the AVM during this time, the mean systemic and feeding artery pressures were roughly similar and remained relatively constant. A slow controlled injection of n-butyl cyanoacrylate glue was then performed, with excellent filling of the nidus.
CONCLUSION: Adenosine-induced cardiac pause may be a viable method of partial flow arrest in the treatment of cerebral AVMs. Safe, deep, and complete embolization with a permanent agent may increase the likelihood of endovascular therapy's being curative or may further improve the safety of microsurgical resection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201317     DOI: 10.1097/00006123-199904000-00117

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  14 in total

1.  Flow arrest intra-arterial delivery of small TAT-decorated and neutral micelles to gliomas.

Authors:  Juliane Nguyen; Shaolie S Hossain; Johann R N Cooke; Jason A Ellis; Michael B Deci; Charles W Emala; Jeffrey N Bruce; Irving J Bigio; Robert M Straubinger; Shailendra Joshi
Journal:  J Neurooncol       Date:  2017-04-18       Impact factor: 4.130

Review 2.  Intraarterial drug delivery for glioblastoma mutiforme: Will the phoenix rise again?

Authors:  Shailendra Joshi; Jason A Ellis; Eugene Ornstein; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2015-06-25       Impact factor: 4.130

3.  Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy.

Authors:  Shailendra Joshi; Johann R N Cooke; Jason A Ellis; Charles W Emala; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2017-09-05       Impact factor: 4.130

4.  Europium fluorescence to visualize N-butyl 2-cyanoacrylate in embolized vessels of an arteriovenous malformation swine model.

Authors:  W J Calvo; B B Lieber; L N Hopkins; A K Wakhloo
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

5.  Transvenous Removal of Glue from Obstructed Straight Sinus during Transarterial Embolization.

Authors:  A Krajina; M Lojik; J Nahlovsky
Journal:  Interv Neuroradiol       Date:  2007-06-27       Impact factor: 1.610

6.  Intra-arterial mitoxantrone delivery in rabbits: an optical pharmacokinetic study.

Authors:  Shailendra Joshi; Roberto Reif; Mei Wang; Jane Zhang; Aysegul Ergin; Jeffery N Bruce; Robert L Fine; Irving J Bigio
Journal:  Neurosurgery       Date:  2011-09       Impact factor: 4.654

7.  Revisiting intra-arterial drug delivery for treating brain diseases or is it "déjà-vu, all over again"?

Authors:  Shailendra Joshi; Jason A Ellis; Charles W Emala
Journal:  J Neuroanaesth Crit Care       Date:  2014-05

Review 8.  Neuroanesthesia and pregnancy: Uncharted waters.

Authors:  Shalendra Singh; Navdeep Sethi
Journal:  Med J Armed Forces India       Date:  2018-12-20

9.  Safety, feasibility, and optimization of intra-arterial mitoxantrone delivery to gliomas.

Authors:  Jason A Ellis; Johann Cooke; Rajinder P Singh-Moon; Mei Wang; Jeffrey N Bruce; Charles W Emala; Irving J Bigio; Shailendra Joshi
Journal:  J Neurooncol       Date:  2016-08-30       Impact factor: 4.130

10.  Transient cerebral hypoperfusion assisted intraarterial cationic liposome delivery to brain tissue.

Authors:  Shailendra Joshi; Rajinder P Singh-Moon; Mei Wang; Durba B Chaudhuri; Mark Holcomb; Ninfa L Straubinger; Jeffrey N Bruce; Irving J Bigio; Robert M Straubinger
Journal:  J Neurooncol       Date:  2014-03-25       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.